Exchange: NASDAQ·Updated 07:30 PM EST

HQY News

News
all
press releases
USS Investment Management Ltd Makes New Investment in HealthEquity, Inc. $HQY
USS Investment Management Ltd bought a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 230,597 shares of the company's stock, valued at a...
MarketBeat
USS Investment Management Ltd Makes New Investment in HealthEquity, Inc. $HQY
USS Investment Management Ltd bought a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 230,597 shares of the company's stock, valued at a...
MarketBeat
More News
HealthEquity (NASDAQ:HQY) Stock Breaks Below 50 Day Moving Average - Here's What Happened...
MarketBeat
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
GW&K Investment Management LLC lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 56.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 989,427 shares of the company's stock after buying an add...
MarketBeat
HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.
Zacks
IceCure Medical (ICCM) delivered earnings and revenue surprises of +51.81% and -3.06%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Aytu BioPharma, Inc. (AYTU) delivered earnings and revenue surprises of -100.00% and +2.36%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Prime Medicine, Inc. (PRME) delivered earnings and revenue surprises of +4.35% and -25.80%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
HQY's strong HSA growth, AI-driven efficiencies and raised fiscal 2027 outlook support momentum, though cybersecurity risks remain a concern.
Zacks
CryoPort (CYRX) delivered earnings and revenue surprises of -31.58% and +3.16%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.